INGN broadens beyond portable oxygen concentrators into home respiratory care, but U.S. revenues face pressure from channel ...
Inogen reported Q4 2025 revenue of about $82 million, up 2% year over year, with full‑year revenue rising 4% to $348.7 million. More telling was unit volume growth above 20% in both the quarter and ...
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results